Categories: Blog

Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details

The Centre has issued a detailed advisory on GLP-1 receptor agonist drugs, emphasizing their use for type 2 diabetes and obesity must be strictly under medical supervision. Authorities are increasing regulatory surveillance and warning of strict action against violations in their sale or prescription.

The News Vista

Leave a Comment
Share
Published by
The News Vista
2 weeks ago

Recent Posts

UP hikes minimum wages across categories amid Noida protest: What workers will now earn

Uttar Pradesh government has approved a significant interim hike of approximately 21% in minimum wages…

1 hour ago

Not seen ‘dirty party’ like BJP, says Mamata Banerjee; flags ‘logical discrepancy’ in SIR process

West Bengal Chief Minister Mamata Banerjee criticized the Election Commission and BJP, alleging selective application…

1 hour ago

Scrambling for financial support: Pakistan eyes Eurobonds, in talks with China & Saudi Arabia after UAE refuses debt roll over

Pakistan is holding talks with Saudi Arabia and China to secure financial assistance as it…

1 hour ago

KKR’s Blessing Muzarabani banned for two years for picking IPL over PSL

PCB banned Muzarabani from the PSL for two years. "In this instance, despite a clear…

2 hours ago

Tamil Nadu assembly polls: CM Stalin holds door-to-door campaign in Vellore

Tamil Nadu Chief Minister M K Stalin campaigned in Vellore for the upcoming Assembly elections.…

2 hours ago

Petrol, diesel losses: What oil firms are losing amid Hormuz supply squeeze

India's state-run oil companies are incurring significant losses, estimated at Rs 18 per litre on…

2 hours ago